Practical guidance for national influenza centres establishing or implementing neuraminidase inhibitor susceptibility surveillance
updated 2018
1 April 2018
| Guidance (normative)

Overview
This document discusses the practical considerations that must be assessed when deciding whether implementation of AVST within a laboratory is practical, the long-term costs of testing, and the requirements for testing in terms of resources (both equipment and reagents) and staff training.
WHO Team
Global Influenza Programme (GIP),
Global Influenza Surveillance and Response System
Number of pages
21
Reference numbers
ISBN: 978-92-4-151666-2